Michael Oberst
6Patents
2h-index
19Co-inventors
40Inventor score
Filing activity: May 27, 2015 → Jun 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9738723B2 | Humanized anti-OX40 antibodies and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US10457732B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US11279759B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9718870B2 | OX40L fusion proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10150815B2 | Method of treating cancer with humanized anti-OX40 antibodies | Chemistry; Metallurgy | 0 | Active |
| USRE49908E1 | Bispecific binding proteins and uses thereof | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.